GGrantIndex
Sort

46,585 grants matching heart failure

Antigenic basis of immune responses after immune modulatory therapies post-HCT

$568,895
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Regulation of Metabolic Genes in the Heart

$568,869
Steven P. Jones · University Of Louisville · R01 · FY2016 · HL

HALF-PINT: Heart And Lung Failure - Pediatric INsulin Titration trial - DCC

$568,846
David Wypij · Boston Children'S Hospital · U01 · FY2012 · HL

A dialogue between neutrophils and monocytes for effective resolution of inflammation following acute myocardial injury

$568,792
Prabhakara Reddy Nagareddy · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · HL

Completely biological tissue-engineered pulmonic valve grown in vitro from human

$568,731
Robert T Tranquillo · University Of Minnesota · R01 · FY2011 · HL

Glycosphingolipid-Mediated Cardiomyocyte and Immune Cell Dysfunction in Hypoplastic Left Heart Syndrome

$568,698
Anastacia M Garcia · University Of Colorado Denver · R01 · FY2025 · HL

The Road to Destination Therapy: Optimizing Long-Term Mechanical Cardiopulmonary Support for Pulmonary Hypertension

$568,633
Matthew Dominic Bacchetta · Vanderbilt University Medical Center · R01 · FY2021 · HL

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot

$568,578
Alexander Egbe · Mayo Clinic Rochester · R01 · FY2023 · HL

Supplemental Oxygen for Pulmonary Embolism (SO-PE) - A Mechanistic Clinical Trial

$568,519
Christopher Kabrhel · Massachusetts General Hospital · R01 · FY2024 · HL

Cellular and Molecular Features of Gene Mutations in Primary Ciliary Dyskinesia

$568,504
Steven Brody · Washington University · R01 · FY2021 · HL

Cellular and Molecular Features of Gene Mutations in Primary Ciliary Dyskinesia

$568,504
Steven Brody · Washington University · R01 · FY2022 · HL

Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart

$568,474
Hind Lal · University Of Alabama At Birmingham · R01 · FY2025 · HL

Surgery to Prevent Post Infarction Ventricular Remodeling

$568,446
Robert C Gorman · University Of Pennsylvania · R01 · FY2018 · HL

Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure

$568,440
Shey-Shing Sheu · Thomas Jefferson University · R01 · FY2025 · HL

Differential regulation of cardiomyocyte survival and hypertrophy

$568,420
Peter Erhardt · Boston Biomedical Research Institute · R01 · FY2009 · HL

Short-course Benznidazole Treatment to Reduce Trypanosoma cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiorityRandomized Controlled Trial

$568,299
Pierre Buekens · Tulane University Of Louisiana · R01 · FY2022 · HD

Stress, Sleep and Emerging CVD Risk Factors

$568,293
Karen A Matthews · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL

Heart and Muscle K+ Channels: Assembly and Regulation

$568,284
Gideon Koren · Rhode Island Hospital · R01 · FY2011 · HL

Senescence and Growth Differentiation Factors as Modifiers of Aging

$568,264
Nathan K Lebrasseur · Mayo Clinic Rochester · R01 · FY2021 · AG

Mosaic Loss of the Y Chromosome in Cardiac Amyloidosis

$568,246
Kenneth Walsh · University Of Virginia · R01 · FY2025 · AG

Risk Burden of Lipoprotein Metabolic Gene Haplotypes

$568,246
Jeffrey Lance Anderson · Ihc Health Services, Inc. · R01 · FY2007 · HL

Design and Simulation of Valvular Replacement Biomaterials

$568,202
Michael S Sacks · University Of Texas At Austin · R01 · FY2014 · HL

E2F2 and Vascular Function

$568,142
Gangjian Qin · University Of Alabama At Birmingham · R01 · FY2019 · HL

E2F2 and Vascular Function

$568,142
Yuji Nakada · University Of Alabama At Birmingham · R01 · FY2020 · HL

Cell Death Pathways and Heart Transplant Rejection

$568,131
Adrian T Ting · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AI